Archives
-
HyperScribe T7 RNA Polymerase Transcription
2026-08-20
The HyperScribe T7 High Yield RNA Synthesis Kit supports scalable T7 RNA polymerase transcription for structured, labeled, and modified RNA. This guide connects transcript design to IRES translation assays, RNA–protein interaction studies, and better mechanistic controls.
-
Leupeptin Hemisulfate: Protease Inhibition Guide
2026-08-20
Leupeptin hemisulfate salt is a reversible, competitive inhibitor used to study serine and cysteine protease activity. Its enzyme-specific potency, limited membrane permeability, solution instability, and application-specific evidence determine how it should be used in protein degradation, viral replication, and autophagy experiments.
-
FAISL–FAK Signaling in Triple-Negative Breast Cancer
2026-08-19
The reference study identifies FAISL as a long noncoding RNA that stabilizes focal adhesion kinase by blocking Calpain 2-mediated proteolysis, thereby promoting triple-negative breast cancer progression and metastasis. Its combination of transcriptomic discovery, interaction mapping, functional assays, and nanoparticle-mediated RNA interference provides a mechanistic framework for studying FAK regulation beyond kinase phosphorylation.
-
Streptavidin-FITC for Trafficking Assay Design
2026-08-19
Streptavidin-FITC converts biotin labeling into a flexible fluorescence readout for imaging, tissue analysis, and flow cytometry. This guide focuses on a less explored question: how to design and interpret biotin-based assays that distinguish cellular uptake from productive intracellular trafficking.
-
NLRP10, Keratinocyte Survival, and Skin Barrier Function
2026-08-18
The reference study identifies NLRP10 as an epidermal homeostatic regulator that links keratinocyte survival with P63-dependent differentiation and barrier formation. Using human atopic dermatitis samples and air-lift human skin equivalents, the authors connect reduced NLRP10 expression to caspase-8-mediated cell death and impaired epidermal maturation, providing a mechanistic framework for studying barrier failure in atopic dermatitis.
-
Aprotinin Workflows for Protease and RBC Research
2026-08-18
Aprotinin enables reversible control of trypsin, plasmin, and kallikrein in protease, inflammatory, and fibrinolysis assays. This practical guide connects inhibitor workflow design with red blood cell membrane mechanics while separating validated product characteristics from assay-development recommendations.
-
Aprotinin in GRO-seq: Workflow and Optimization
2026-08-17
Aprotinin can add a protease-control layer to nuclei-based nascent RNA workflows without replacing strict RNase-free technique. This article connects bovine pancreatic trypsin inhibitor chemistry with the reference study’s rRNA-depleted GRO-seq strategy, offering practical setup, optimization, and troubleshooting guidance for complex genomes.
-
Haloprogin: From MICs to Translational Strategy
2026-08-17
A thought-leadership analysis of Haloprogin that connects its antimicrobial spectrum and unresolved mechanism with experimental design, formulation strategy, comparator selection, and translational decision-making.
-
Streptavidin-FITC for Biotin Trafficking Assays
2026-08-16
Streptavidin-FITC combines high-affinity biotin recognition with FITC fluorescence for tracking labeled nucleic acids, proteins, and nanoparticles. This guide translates a recent lipid nanoparticle trafficking study into practical imaging, flow cytometry, immunohistochemistry, and troubleshooting workflows.
-
Rapamycin (Sirolimus): Reliable Assay Workflows
2026-08-15
This scenario-driven guide explains how Rapamycin (Sirolimus), SKU A8167, can improve interpretation of cell viability, proliferation, and cytotoxicity assays through concentration-response design, solvent control, and orthogonal validation. It also provides practical criteria for comparing suppliers and handling mTOR inhibitor stocks.
-
JSH-23: A Strategic Lens on NF-κB Translation
2026-08-14
JSH-23 offers translational researchers a mechanistically defined way to interrogate NF-κB p65 nuclear localization and transcription, connecting macrophage inflammation assays with preclinical kidney injury models while clarifying the limits of pathway-level inference.
-
CAY10499: A Mechanistic Guide to Lipid Flux
2026-08-14
CAY10499 is an inhibitor of human hormone sensitive lipase and monoglyceride lipase for separating lipid synthesis from lipid hydrolysis in metabolic assays. This guide connects its biochemical profile with extracellular-vesicle-driven macrophage programming while emphasizing assay design, selectivity, and interpretation limits.
-
SMPD4, Ceramide, and Primary Cilia Development
2026-08-13
A 2024 Development study links SMPD4-dependent ceramide production to brain morphogenesis, Purkinje cell development, neural progenitor survival, and primary cilium maintenance. By combining a mouse model with SMPD4-deficient human iPSC-derived neural cells and a ceramide-rescue experiment, the work provides mechanistic evidence connecting sphingolipid metabolism with microcephaly and cerebellar hypoplasia.
-
Cepharanthine Workflows for Apoptosis Research
2026-08-13
Cepharanthine supports a practical, multi-model workflow spanning stromal-cell viability assays, patient-derived endometrial organoids, and lesion-level mechanistic validation. Its value is greatest when apoptosis, DNA damage, cell-cycle arrest, and immunomodulatory or oncology-adjuvant questions are measured together rather than inferred from a single viability endpoint.
-
T0070907: Turning PPARγ Antagonism into Insight
2026-08-12
T0070907 offers translational researchers a high-affinity, covalent PPARγ perturbation tool for testing receptor dependence across adipogenesis, inflammation, and cancer cell-cycle models. By connecting the RXRα/PPARγ/NEDD4 findings reported in atherosclerosis with disciplined cellular validation, this article provides a strategy for moving from pathway association to causal insight.
548 records 7/37 page Previous Next First page 上5页 678910 下5页 Last page